propranolol has been researched along with Eyelid Neoplasms in 26 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Eyelid Neoplasms: Tumors of cancer of the EYELIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management." | 7.80 | Monitoring propranolol treatment in periocular infantile haemangioma. ( Burne, R; Taylor, R, 2014) |
| "This case of a four and a half-month-old girl describes periocular infantile haemangioma which was treated successfully with propranolol." | 7.79 | Periocular infantile haemangioma and the role of propranolol. ( Ahmad, K; Chaudhry, TA; Kamal, M, 2013) |
| "Infants can benefit from a rapid, meaningful reduction in periocular capillary hemangioma-induced astigmatism following oral propranolol treatment." | 7.77 | Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma. ( Ben-Zion, I; Fabian, ID; Samuel, C; Spierer, A, 2011) |
| " Our main outcome measures were colour and size of infantile haemangioma before and after treatment, the change in astigmatism of our patients and the incidence of complications from propranolol." | 7.76 | Propranolol in the management of periorbital infantile haemangioma. ( Cheng, JF; Gole, GA; Sullivan, TJ, 2010) |
| "To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management." | 3.80 | Monitoring propranolol treatment in periocular infantile haemangioma. ( Burne, R; Taylor, R, 2014) |
| "This case of a four and a half-month-old girl describes periocular infantile haemangioma which was treated successfully with propranolol." | 3.79 | Periocular infantile haemangioma and the role of propranolol. ( Ahmad, K; Chaudhry, TA; Kamal, M, 2013) |
| "Infants can benefit from a rapid, meaningful reduction in periocular capillary hemangioma-induced astigmatism following oral propranolol treatment." | 3.77 | Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma. ( Ben-Zion, I; Fabian, ID; Samuel, C; Spierer, A, 2011) |
| " Our main outcome measures were colour and size of infantile haemangioma before and after treatment, the change in astigmatism of our patients and the incidence of complications from propranolol." | 3.76 | Propranolol in the management of periorbital infantile haemangioma. ( Cheng, JF; Gole, GA; Sullivan, TJ, 2010) |
| " Additional research may confirm the best dosage and route of administration to maximize efficacy in reducing induced astigmatism and amblyopia associated with periocular hemangiomas while minimizing side effects." | 2.61 | The Use of β-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by the American Academy of Ophthalmology. ( Galvin, JA; Hutchinson, AK; Kraker, RT; Lambert, SR; Pineles, SL; VanderVeen, DK; Wilson, LB, 2019) |
| "Oral propranolol treatment caused a 47% reduction in mean induced astigmatism, less than the 63% reduction reported for the cohort treated with corticosteroid." | 1.43 | Visual acuity and astigmatism in periocular infantile hemangiomas treated with oral beta-blocker versus intralesional corticosteroid injection. ( Herlihy, EP; Kelly, JP; Perkins, JA; Sidbury, R; Weiss, AH, 2016) |
| "Propranolol was stopped in 1 case for hypotension and in 1 case for allergy." | 1.39 | Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol. ( Di Mezza, A; Forte, R; Magli, A; Vassallo, P, 2013) |
| "Propranolol seems to be an effective modality of treatment for periocular IH." | 1.37 | Treatment of periocular infantile hemangiomas with propranolol: case series of 18 children. ( Al Dhaybi, R; Chevrette, L; Codère, F; Dubois, J; Fallaha, N; Hamel, P; Hatami, A; McCuaig, C; Milet, A; Ospina, LH; Powell, J; Superstein, R, 2011) |
| "Oral propranolol for treatment of infantile hemangiomas was effective in all patients, with 33% reduction in astigmatism and 39% reduction in surface area." | 1.37 | Oral propranolol for treatment of periocular infantile hemangiomas. ( Bayliss, SJ; Gilbertson, K; Lueder, GT; Missoi, TG, 2011) |
| " A treatment dosage of 2 mg/kg per day was started at mean age 5." | 1.37 | Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. ( Ben-Amitay, D; Friling, R; Goldenberg-Cohen, N; Reich, U; Ron, Y; Siegel, R; Snir, M; Zvulunov, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 25 (96.15) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Ojha, HR | 1 |
| Verma, N | 1 |
| Howard, MA | 1 |
| Olitsky, SE | 1 |
| Rychwalski, P | 1 |
| Mungan, N | 1 |
| Mehta, A | 1 |
| Bajaj, MS | 1 |
| Pushker, N | 1 |
| Chawla, B | 1 |
| Pujari, A | 1 |
| Grewal, SS | 1 |
| Grewal, SPS | 1 |
| Singh, SR | 1 |
| Kishore, A | 1 |
| Yadav, NS | 1 |
| Tripathy, D | 1 |
| Abdellaoui, T | 1 |
| Laaribi, N | 1 |
| Zerrouk, R | 1 |
| Elasri, F | 1 |
| Reda, K | 1 |
| Oubaaz, A | 1 |
| Hutchinson, AK | 1 |
| Kraker, RT | 1 |
| Pineles, SL | 1 |
| VanderVeen, DK | 1 |
| Wilson, LB | 1 |
| Galvin, JA | 1 |
| Lambert, SR | 1 |
| Yen, KG | 1 |
| Hussein, MA | 1 |
| Chaudhry, TA | 1 |
| Kamal, M | 1 |
| Ahmad, K | 1 |
| Burne, R | 1 |
| Taylor, R | 1 |
| Herlihy, EP | 1 |
| Kelly, JP | 1 |
| Sidbury, R | 1 |
| Perkins, JA | 1 |
| Weiss, AH | 1 |
| Rizvi, SA | 1 |
| Mehmood, F | 1 |
| Agrawal, A | 1 |
| Manunza, F | 1 |
| Syed, S | 1 |
| Laguda, B | 1 |
| Linward, J | 1 |
| Kennedy, H | 1 |
| Gholam, K | 1 |
| Glover, M | 1 |
| Giardini, A | 1 |
| Harper, JI | 1 |
| Cheng, JF | 1 |
| Gole, GA | 1 |
| Sullivan, TJ | 1 |
| Fabian, ID | 1 |
| Ben-Zion, I | 1 |
| Samuel, C | 1 |
| Spierer, A | 1 |
| Al Dhaybi, R | 1 |
| Superstein, R | 1 |
| Milet, A | 1 |
| Powell, J | 1 |
| Dubois, J | 1 |
| McCuaig, C | 1 |
| Codère, F | 1 |
| Hatami, A | 1 |
| Chevrette, L | 1 |
| Fallaha, N | 1 |
| Hamel, P | 1 |
| Ospina, LH | 1 |
| Wester, ST | 1 |
| Johnson, TE | 1 |
| Missoi, TG | 1 |
| Lueder, GT | 1 |
| Gilbertson, K | 1 |
| Bayliss, SJ | 1 |
| Spierer, O | 1 |
| Neudorfer, M | 1 |
| Leibovitch, I | 1 |
| Stolovitch, C | 1 |
| Kessler, A | 1 |
| Thoumazet, F | 1 |
| Léauté-Labrèze, C | 1 |
| Colin, J | 1 |
| Mortemousque, B | 1 |
| Ni, N | 1 |
| Guo, S | 1 |
| Langer, P | 1 |
| Snir, M | 1 |
| Reich, U | 1 |
| Siegel, R | 1 |
| Zvulunov, A | 1 |
| Friling, R | 1 |
| Goldenberg-Cohen, N | 1 |
| Ron, Y | 1 |
| Ben-Amitay, D | 1 |
| Williams, K | 1 |
| Woolf, R | 1 |
| Morrison, D | 1 |
| Janmohamed, SR | 1 |
| Madern, GC | 1 |
| Nieuwenhuis, K | 1 |
| de Laat, PC | 1 |
| Oranje, AP | 1 |
| Vassallo, P | 1 |
| Forte, R | 1 |
| Di Mezza, A | 1 |
| Magli, A | 1 |
| Xue, K | 1 |
| Hildebrand, GD | 1 |
| Salazar-Murillo, R | 1 |
| García-Pacheco, S | 1 |
| González-Blanco, MJ | 1 |
| Bolívar-Montesa, P | 1 |
| Campos-García, S | 1 |
2 reviews available for propranolol and Eyelid Neoplasms
| Article | Year |
|---|---|
The Use of β-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Hemangiom | 2019 |
Current concepts in the management of periocular infantile (capillary) hemangioma.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Eyelid | 2011 |
2 trials available for propranolol and Eyelid Neoplasms
| Article | Year |
|---|---|
To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; | 2019 |
Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol.
Topics: Adrenal Cortex Hormones; Eyelid Neoplasms; Female; Hemangioma; Humans; Infant, Newborn; Injections, | 2012 |
22 other studies available for propranolol and Eyelid Neoplasms
| Article | Year |
|---|---|
Early management of capillary haemangioma to prevent stimulus-deprivation amblyopia.
Topics: Amblyopia; Child; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Propranolol; Timo | 2022 |
Management of Periocular Infantile Hemangioma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Glucocorticoids; Hemang | 2019 |
Commentary: Propranolol for infantile hemangiomas - The intralesional route.
Topics: Eyelid Neoplasms; Hemangioma; Hemangioma, Capillary; Humans; Propranolol | 2019 |
[Giant infantile hemangioma of the eyelid].
Topics: Abdominal Neoplasms; Eyelid Neoplasms; Eyelids; Female; Hemangioma; Humans; Infant; Propranolol; Tum | 2017 |
Oral propranolol in the management of periocular capillary hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; | 2013 |
Periocular infantile haemangioma and the role of propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma; Humans; Inf | 2013 |
Monitoring propranolol treatment in periocular infantile haemangioma.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Amblyopia; Child; Child, Preschool; D | 2014 |
Visual acuity and astigmatism in periocular infantile hemangiomas treated with oral beta-blocker versus intralesional corticosteroid injection.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Astigmatism; Eyelid Neoplasms; Female; Glucocorti | 2016 |
Bilateral congenital infantile hemangioma of upper eyelids.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Eyelid Neoplasms; Eyelids; Female; Hemangioma, Ca | 2016 |
Propranolol for complicated infantile haemangiomas: a case series of 30 infants.
Topics: Adrenergic beta-Antagonists; Eyelid Neoplasms; Facial Neoplasms; Female; Follow-Up Studies; Glottis; | 2010 |
Propranolol in the management of periorbital infantile haemangioma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Astigmatism; Eyelid Neoplasms; Female; Hemangioma | 2010 |
Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Astigmatism; Blood Pressure; Eyelid Neoplasms; Fe | 2011 |
Treatment of periocular infantile hemangiomas with propranolol: case series of 18 children.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Eyelid Neoplasms; Female; Follow-Up Studies; | 2011 |
Echographic evidence of regression of a periocular infantile capillary hemangioma treated with systemic propranolol.
Topics: Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Off-La | 2011 |
Oral propranolol for treatment of periocular infantile hemangiomas.
Topics: Administration, Oral; Antineoplastic Agents; Child, Preschool; Eyelid Neoplasms; Female; Hemangioma, | 2011 |
Colour Doppler ultrasound imaging findings in paediatric periocular and orbital haemangiomas.
Topics: Adrenergic beta-Antagonists; Blood Flow Velocity; Eyelid Neoplasms; Female; Follow-Up Studies; Gluco | 2012 |
Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Follow-Up Stu | 2012 |
Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.
Topics: Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; | 2011 |
Periocular lesion in an infant.
Topics: Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Laser | 2011 |
Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Child; Child, Preschool; Eyelid Neoplasms; Female | 2013 |
Topical timolol maleate 0.5% for infantile capillary haemangioma of the eyelid.
Topics: Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; Orbital Neoplasms; Pro | 2012 |
[Propranolol: Treatment of capillary hemangioma with orbital involvement].
Topics: Disease Progression; Eyelid Neoplasms; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Infa | 2012 |